Synthetic virus particles to study COVID-19

The Sars-CoV-2 pandemic has been and is still one of the main global health concerns. Completely understanding Sars-CoV-2 pathogenesis and the molecular mechanisms behind the infection yields great opportunities to overcome the pandemic. Shedding light upon viral functions and host-virus interactions will facilitate the development of targeted therapies, vaccines or other preventive measures, writes the Max Planck Institute in this press release. However, research on Sars-CoV-2 in the laboratory environment comes with many challenges. One is the increased safety requirement for experiments, another is studying distinct mechanisms during the infection rather than the whole pathogenesis to better understand those single processes.

Building artificial SARS-CoV-2 virions

Researchers at the Max Planck Institute for Medical Research and their collaborators used their expertise in bottom-up synthetic biology to overcome some of those challenges. For their study, they developed artificial Sars-CoV-2 virions. The virions have a similar structure to natural viruses but do not contain any genetic information. Therefore, they can be used safely.

“Even more important for us, as we build these synthetic virions from scratch, is that we can precisely design their composition and structure. This allows us to perform a very systematic, step-by-step study on distinct mechanisms”, says Oskar Staufer, first author of the paper, former postdoc at the Max Planck Institute for Medical Research and current postdoc at the University of Oxford. He therefore sees great potential in using the synthetic virus-like particles in a multitude of analysis and characterization pipelines to study viruses beyond the current application for Sars-CoV-2.

Spike protein switching mechanism to avoid the immune system?

They first used the artificial minimalistic virions to study the effect of inflammatory fatty acids on the spike protein of Sars-CoV-2. Inflammatory fatty acids are released during any inflammation in the body and they help facilitate immune response and healing processes. The spike protein is critical for host-virus interaction. On the one hand the virus uses the spike protein to bind to the host cells ACE2 receptors. This enables the virus to fuse with the host cell and release its genetic information. On the other hand, antibodies produced by the host can bind to the spike protein, thereby marking the virus a target for the immune system.

It was known before, that the spike protein has a distinct region where inflammatory fatty acids can bind. However, the function of this binding pocket was previously not understood. Researchers at the Max Planck Institute for Medical Research and collaborators in Bristol now used the artificial Sars-CoV-2 virions to study this exact mechanism. They show that upon binding of a fatty acid, the spike protein changes its conformation and “folds”. As a result, binding to the ACE2 receptor of the host is no longer possible and fewer antibodies can bind to the protein.

Understanding the mechanism to develop therapy

Researchers can now start to understand why this cowering mechanism is used by the virus and determine whether this information can be used to develop therapeutic strategies. “By “ducking down” of the spike protein upon binding of inflammatory fatty acids, the virus becomes less visible to the immune system. This could be a mechanism to avoid detection by the host and a strong immune response for a longer period of time and increase total infection efficiency”, says Oskar Staufer. However, scientists are just at the beginning of determining the function of the folding mechanism, but the use of artificial virions will allow for a systematic approach. “Applying such synthetic biology concepts to a problem with global impact is truly exciting!”, says Oskar Staufer.

Also interesting: Corona in Europe – 5 major corona blunders in 2 years of pandemic